Hadasit Bio Holdings Flagship Portfolio Company Enlivex Therapeutics Ltd. Awarded Orphan Drug Status for ApoCell, Inc. Treatment by the FDA
4/4/2013 10:18:21 AM
More...
|
Enlivex Therapeutics Ltd. Announces Positive Results in Completion of Clinical Trial for the Treatment of Bone Marrow Transplant Recipients
10/25/2012 9:40:27 AM
More...
|
Enlivex Therapeutics Ltd. Announces Positive Results in Completion of Clinical Trial for the Treatment of Bone Marrow Transplant Recipients
10/24/2012 10:37:09 AM
More...
|
Enlivex Therapeutics Ltd. Completes Patient Enrollment in its Phase I/II Clinical Trial
1/23/2012 6:33:08 AM
More...
|
Clinical Developments at Enlivex Therapeutics Ltd - a Hadasit Bio-Holdings Ltd. (HDST) Portfolio Company
8/17/2011 11:00:06 AM
More...
|